Delivery Order HHSN272201100016I-HHSN27200014
Award Date
8/22/17
Potential Completion Date
9/15/18
Potential Value
$846K
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Birmingham, AL 35233, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) for in vitro assessment of antimicrobial activity. The contract has a ceiling value of $1,282,905.51 and was awarded on September 17, 2012, with a completion date of September 16, 2013. The contract is under a larger Indefinite Delivery Contract (IDC) vehicle named "In Vitro Antimicrobial...
This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) as a Delivery Order. The contract is for "IN VITRO ASSESSMENTS FOR ANTIMICROBIAL ACTIVITY" and is part of the larger "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The contract has a ceiling value of $1,277,140.50 and a...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Delivery Order to the University of Alabama at Birmingham (UAB), doing business as U A B, for a "COMPREHENSIVE PANEL FOR VIRUSES" contract with a ceiling value of $1,053,577.42. The contract is under the broader In Vitro Antimicrobial Assessments 2011-2018 Indefinite Delivery Contract (IDC) and has a completion date of September 29, 2016. UAB is a non-profit, public research university...
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) under the In Vitro Antimicrobial Assessments 2011-2018 IDIQ contract. The contract, which does not have a set-aside designation, is for $216,637.50 and covers in vitro antimicrobial assessments under Task B07. UAB, a leading public research university and academic medical center,...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $978,590.76 Firm Fixed Price Delivery Order to the University of Alabama at Birmingham (UAB) on August 15, 2014 for a "Comprehensive Panel for Viruses" requirement. This Delivery Order was placed under NIAID's In Vitro Antimicrobial Assessments 2011-2018 Indefinite Delivery, Indefinite Quantity (IDIQ) contract and had a completion date of September 29, 2015. UAB, a public research university and academic...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) to provide in vitro assessments for antimicrobial activity. The contract, valued at $12,178, is a delivery order under the larger "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery Contract (IDC) vehicle. The award has a completion date of November 14, 2013,...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $499,760.00 firm fixed-price delivery order contract to the University of Alabama at Birmingham (UAB) for in vitro assessments of antimicrobial activity. This contract is under the parent "In Vitro Assessments of Antimicrobial Activity (IVAAA)" Indefinite Delivery Contract (IDC). UAB, a non-profit, state-controlled institution of higher...
This federal contract award, with an ID of HHSN272201100016I|HHSN27200013, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government. The contract is for "IN VITRO ASSESSMENT FOR ANTIMICROBIAL ACTIVITY" and was awarded to the University of Alabama at Birmingham (UAB), a public research university, on September 13, 2016. The contract has a ceiling value of $1,066,560.00 and runs through September 15, 2017. It is a...
The University of Alabama at Birmingham (UAB) was awarded a $1,082 Firm Fixed Price delivery order contract by the National Institute of Allergy and Infectious Diseases (NIAID) to conduct in vitro assessments of antimicrobial activity. This contract is part of the "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery Contract (IDC) for NIAID. UAB, a public research university and academic medical center, has significant expertise in biomedical research, healthcare...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Alabama at Birmingham (UAB) to provide a "SUPPLEMENT TO COMPREHENSIVE PANEL FOR VIRUSES". The $26,500.00 Firm Fixed Price contract was awarded on March 24, 2015 as a Delivery Order under the "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery Contract (IDC). The contract has no set-aside designation. As a leading...